Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
Open Access
- 1 September 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (17)
Abstract
The in vivo persistence of adoptively transferred T cells is predictive of antitumor response. Identifying functional properties of infused T cells that lead to in vivo persistence and tumor eradication has remained elusive. We profiled CD19-specific chimeric antigen receptor (CAR) T cells as the infusion products used to treat large B cell lymphomas using high-throughput single-cell technologies based on time-lapse imaging microscopy in nanowell grids (TIMING), which integrates killing, cytokine secretion, and transcriptional profiling. Our results show that the directional migration of CD19-specific CAR T cells is correlated with multifunctionality. We showed that CD2 on T cells is associated with directional migration and that the interaction between CD2 on T cells and CD58 on lymphoma cells accelerates killing and serial killing. Consistent with this, we observed that elevated CD58 expression on pretreatment tumor samples in patients with relapsed or refractory large B cell lymphomas treated with CD19-specific CAR T cell therapy was associated with complete clinical response and survival. These results highlight the importance of studying dynamic T cell–tumor cell interactions in identifying optimal antitumor responses.Keywords
All Related Versions
Funding Information
- NIGMS (R01GM143243)
- National Institutes of Health (P30 CA016672)
- CPRIT (RP180466)
- Melanoma Research Alliance (509800)
- National Science Foundation (1705464)
- Owens Foundation (NV)
- CDMRP (CA160591)
- CRISP Therapeutics (FV)
This publication has 55 references indexed in Scilit:
- T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responsesBiochemical Journal, 2014
- Analysis of Host Gene Expression Changes Reveals Distinct Roles for the Cytoplasmic Domain of the Epstein-Barr Virus Receptor/CD21 in B-Cell Maturation, Activation, and Initiation of Virus InfectionJournal of Virology, 2014
- Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical TrialsPLOS ONE, 2013
- Quantitative High-throughput Single-cell Cytotoxicity Assay For T CellsJournal of Visualized Experiments, 2013
- Ligation of the CD2 co-stimulatory receptor enhances IL-2 production from first-generation chimeric antigen receptor T cellsGene Therapy, 2011
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell LymphomaCancer Cell, 2011
- Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in MiceClinical Cancer Research, 2011
- CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanismExperimental Hematology, 1999
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytesNature, 1989